ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669517 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669517; 2) Community: the network communities that were significantly associated with the response to NSC 669517; 3) Molecule: the relationships between components within communities and NSC 669517; 4) MDR: the compounds that were significantly associated with the NSC 669517.

NSC Compound Enrichment Correlation
NSC 91745 9H-Purine, 6-[(1-methyl-4-nitroimidazol-5-yl)thio]-9-.beta.-D-ribofuranosyl-, compd. with ethyl alcohol (4:1) 0.0219468083770723 -0.11729428
NSC 93077 Null 0.0219468083770723 -0.13161077
NSC 685981 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- 0.0221886141818656 0.14391786
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.022188614181866 -0.23739194
NSC 328410 Camptothecin Derivative 0.022188614181866 -0.16317103
NSC 629229 Null 0.022188614181866 0.37866554
NSC 633514 Null 0.022188614181866 0.14082968
NSC 674182 Null 0.022188614181866 -0.28922025
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.022188614181866 0.70457464
NSC 681633 Camptothecin Derivative 0.022188614181866 -0.070217445
Total:46  Current:21    [First] [Prev] [Next] [Last]